Difficulty: Medium
Average Score: 95%
Practice
Which serum enzyme would elevate first after an infarction?
Correct answer
C
Rationale
In the context of a myocardial infarction (MI), the correct answer is C) Creatine phosphokinase isoenzymes (CPK-MB) because CPK-MB is a specific marker for cardiac muscle damage. CPK is predominantly found in the heart, brain, and skeletal muscle, with CPK-MB being the cardiac-specific isoenzyme. After an MI, the damaged heart muscle releases CPK-MB into the bloodstream, making it one of the earliest markers to elevate.
Option A) Serum glutamic-oxaloacetic transaminase (SGOT) is not a specific marker for cardiac injury and is found in multiple organs, including the liver and heart. Option B) Lactic acid dehydrogenase (LDH) is also not specific to cardiac muscle and can be elevated in various conditions, including liver disease. Option D) Serum glutamic-pyruvic transaminase (SGPT) is primarily a liver enzyme and not specific to myocardial damage.
Educationally, understanding the kinetics and specificity of cardiac enzymes post-MI is crucial for accurate diagnosis and management of patients presenting with chest pain or other cardiac symptoms. Monitoring CPK-MB levels, along with troponin and other cardiac markers, helps in the timely identification of myocardial damage and initiation of appropriate interventions to reduce morbidity and mortality associated with cardiac events.
Option A) Serum glutamic-oxaloacetic transaminase (SGOT) is not a specific marker for cardiac injury and is found in multiple organs, including the liver and heart. Option B) Lactic acid dehydrogenase (LDH) is also not specific to cardiac muscle and can be elevated in various conditions, including liver disease. Option D) Serum glutamic-pyruvic transaminase (SGPT) is primarily a liver enzyme and not specific to myocardial damage.
Educationally, understanding the kinetics and specificity of cardiac enzymes post-MI is crucial for accurate diagnosis and management of patients presenting with chest pain or other cardiac symptoms. Monitoring CPK-MB levels, along with troponin and other cardiac markers, helps in the timely identification of myocardial damage and initiation of appropriate interventions to reduce morbidity and mortality associated with cardiac events.